|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,066.00 GBX | +2.89% |
|
+3.58% | +9.93% |
| 17/07 | Utility stocks support FTSE 100 in nervy trade | AN |
| 17/07 | WINNERS & LOSERS: Vega ups Vodafone stake; GSK drug trial disappoints | AN |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.77 | 2.66 | 2.35 | 2.41 | 3.23 | |||||
Return on Total Capital | 3.93 | 3.87 | 3.37 | 3.36 | 4.45 | |||||
Return On Equity % | -7.26 | 11.83 | 10 | 12.73 | 20.54 | |||||
Return on Common Equity | -7.26 | 11.83 | 10 | 12.73 | 20.54 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 27.25 | 24.63 | 22.95 | 25.76 | 32.39 | |||||
SG&A Margin | 0.34 | 0.17 | 0.57 | 0.43 | 0.25 | |||||
EBITDA Margin % | 44.3 | 40.97 | 37.92 | 40.9 | 46.2 | |||||
EBITA Margin % | 25.75 | 23.43 | 21.3 | 24.01 | 30.63 | |||||
EBIT Margin % | 25.64 | 23.33 | 21.21 | 23.9 | 30.52 | |||||
Income From Continuing Operations Margin % | -4.48 | 6.11 | 6 | 9.45 | 13.1 | |||||
Net Income Margin % | -4.48 | 6.11 | 6 | 9.45 | 13.1 | |||||
Net Avail. For Common Margin % | -4.48 | 6.11 | 6 | 9.45 | 13.1 | |||||
Normalized Net Income Margin | 8.79 | 4.85 | 5.38 | 8.24 | 11.79 | |||||
Levered Free Cash Flow Margin | -4.72 | -12.46 | -29.83 | -36.33 | -41.33 | |||||
Unlevered Free Cash Flow Margin | 3.69 | -1.97 | -21.6 | -28.94 | -33.56 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.17 | 0.18 | 0.18 | 0.16 | 0.17 | |||||
Fixed Assets Turnover | 0.19 | 0.2 | 0.21 | 0.19 | 0.2 | |||||
Receivables Turnover (Average Receivables) | 7.72 | 7.26 | 6.65 | 6.4 | 6.62 | |||||
Inventory Turnover (Average Inventory) | 45.15 | 48.42 | 47.72 | 43.26 | 42.07 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.74 | 0.76 | 2.14 | 1.37 | 1.39 | |||||
Quick Ratio | 0.67 | 0.71 | 2.05 | 1.31 | 1.3 | |||||
Operating Cash Flow to Current Liabilities | 0.84 | 0.69 | 0.96 | 0.63 | 0.98 | |||||
Days Sales Outstanding (Average Receivables) | 47.29 | 50.26 | 55 | 57.04 | 55.12 | |||||
Days Outstanding Inventory (Average Inventory) | 8.08 | 7.54 | 7.67 | 8.44 | 8.68 | |||||
Average Days Payable Outstanding | 16.71 | 23.64 | 28.89 | 33.98 | 33.95 | |||||
Cash Conversion Cycle (Average Days) | 38.67 | 34.16 | 33.77 | 31.5 | 29.84 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 535.7 | 753.55 | 450.94 | 547.61 | 596.63 | |||||
Total Debt / Total Capital | 84.27 | 88.28 | 81.85 | 84.56 | 85.65 | |||||
LT Debt/Equity | 506.8 | 720.85 | 447.24 | 517.51 | 576.75 | |||||
Long-Term Debt / Total Capital | 79.72 | 84.45 | 81.18 | 79.91 | 82.79 | |||||
Total Liabilities / Total Assets | 89.06 | 92.01 | 87.09 | 88.87 | 89.52 | |||||
EBIT / Interest Expense | 1.91 | 1.39 | 1.61 | 2.02 | 2.45 | |||||
EBITDA / Interest Expense | 3.31 | 2.45 | 2.9 | 3.48 | 3.74 | |||||
(EBITDA - Capex) / Interest Expense | 0.98 | 0.53 | -0.9 | -1.93 | -1.65 | |||||
Total Debt / EBITDA | 7.81 | 8.21 | 9.27 | 9.71 | 8.35 | |||||
Net Debt / EBITDA | 7.68 | 8.17 | 8.2 | 8.66 | 7.75 | |||||
Total Debt / (EBITDA - Capex) | 26.37 | 38.25 | -29.77 | -17.51 | -18.91 | |||||
Net Debt / (EBITDA - Capex) | 25.92 | 38.07 | -26.34 | -15.61 | -17.54 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 6.64 | 11.11 | 8 | 3.78 | 16.65 | |||||
Gross Profit, 1 Yr. Growth % | 3.25 | 0.43 | 0.62 | 16.43 | 43.51 | |||||
EBITDA, 1 Yr. Growth % | 6.19 | 2.75 | -0.03 | 11.92 | 30.02 | |||||
EBITA, 1 Yr. Growth % | 6.54 | 1.1 | -1.83 | 16.99 | 45.47 | |||||
EBIT, 1 Yr. Growth % | 6.57 | 1.1 | -1.84 | 16.94 | 45.7 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -141.09 | -251.61 | 6.05 | 63.62 | 62.01 | |||||
Net Income, 1 Yr. Growth % | -141.09 | -251.61 | 6.05 | 63.62 | 62.01 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -139.73 | -249.15 | -3.05 | 50.1 | 61.13 | |||||
Normalized Net Income, 1 Yr. Growth % | 2.58 | -38.74 | 19.89 | 59.02 | 59.88 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.32 | 4.91 | 9.81 | 12.92 | 13.18 | |||||
Inventory, 1 Yr. Growth % | 3.9 | 10.62 | 13.28 | 7.73 | 11.63 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.72 | 31.48 | 7.47 | 8.35 | 16.46 | |||||
Total Assets, 1 Yr. Growth % | 4.82 | 5.14 | 16.92 | 12.01 | 10.44 | |||||
Tangible Book Value, 1 Yr. Growth % | 12.56 | -30.28 | 121.54 | -5.72 | 1.24 | |||||
Cash From Operations, 1 Yr. Growth % | 1.37 | -15.86 | 8.54 | 12.17 | 38.55 | |||||
Capital Expenditures, 1 Yr. Growth % | -0.55 | 14.65 | 67.17 | 32.77 | 22.09 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 97.72 | 193.01 | 158.59 | 26.37 | 34.04 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 7.08 | -159.53 | 1.08T | 39.02 | 36.99 | |||||
Dividend Per Share, 1 Yr. Growth % | 0.55 | 4.58 | 9.38 | 4.17 | 3.54 | |||||
Common Equity, 1 Yr. Growth % | 10.99 | -23.21 | 88.96 | -3.45 | 3.95 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.62 | 8.85 | 9.54 | 5.87 | 10.03 | |||||
Gross Profit, 2 Yr. CAGR % | -6.78 | 1.83 | 0.53 | 8.26 | 30.7 | |||||
EBITDA, 2 Yr. CAGR % | -1.32 | 4.45 | 1.35 | 5.77 | 21.46 | |||||
EBITA, 2 Yr. CAGR % | -5.27 | 3.78 | -0.38 | 7.16 | 31.95 | |||||
EBIT, 2 Yr. CAGR % | -5.29 | 3.8 | -0.38 | 7.14 | 32 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -25.9 | -21.07 | 26.8 | 31.73 | 62.67 | |||||
Net Income, 2 Yr. CAGR % | -25.9 | -21.07 | 26.8 | 31.73 | 62.67 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -27.14 | -23.02 | 20.25 | 20.63 | 55.51 | |||||
Normalized Net Income, 2 Yr. CAGR % | -6.81 | -20.73 | -14.3 | 38.08 | 62.87 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.19 | 4.11 | 7.33 | 11.35 | 13.05 | |||||
Inventory, 2 Yr. CAGR % | 4.68 | 7.21 | 11.94 | 10.47 | 9.41 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.18 | 17.34 | 18.87 | 7.91 | 12.42 | |||||
Total Assets, 2 Yr. CAGR % | 3.42 | 4.98 | 10.87 | 14.44 | 11.22 | |||||
Common Equity, 2 Yr. CAGR % | 0.81 | -7.68 | 20.46 | 35.07 | 0.19 | |||||
Tangible Book Value, 2 Yr. CAGR % | -0.22 | -11.41 | 24.28 | 44.52 | -2.33 | |||||
Cash From Operations, 2 Yr. CAGR % | -0.21 | -7.65 | -4.43 | 10.34 | 24.72 | |||||
Capital Expenditures, 2 Yr. CAGR % | -11.39 | 6.78 | 38.44 | 48.98 | 27.32 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -38.02 | 140.69 | 175.26 | 80.77 | 29.51 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -25.51 | -20.16 | 165.23 | 305.3 | 37.13 | |||||
Dividend Per Share, 2 Yr. CAGR % | 1.02 | 2.55 | 6.95 | 6.74 | 3.85 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.92 | 5.38 | 8.57 | 7.59 | 9.35 | |||||
Gross Profit, 3 Yr. CAGR % | -3.91 | -4.44 | 1.42 | 5.58 | 19.8 | |||||
EBITDA, 3 Yr. CAGR % | -0.46 | 0.02 | 2.93 | 4.76 | 13.82 | |||||
EBITA, 3 Yr. CAGR % | -3.58 | -3.19 | 1.88 | 5.1 | 19.56 | |||||
EBIT, 3 Yr. CAGR % | -3.67 | -3.21 | 1.88 | 5.09 | 19.59 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -34.85 | -5.93 | -12.9 | 38.05 | 41.05 | |||||
Net Income, 3 Yr. CAGR % | -34.85 | -5.93 | -12.9 | 38.05 | 41.05 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -35.83 | -7.48 | -16.87 | 29.47 | 32.85 | |||||
Normalized Net Income, 3 Yr. CAGR % | -11.41 | -18.97 | -9.01 | 5.31 | 47.06 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.4 | 3.76 | 5.98 | 9.16 | 11.96 | |||||
Inventory, 3 Yr. CAGR % | 15.44 | 6.63 | 9.19 | 10.52 | 10.68 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.66 | 9.68 | 13.95 | 15.26 | 10.74 | |||||
Total Assets, 3 Yr. CAGR % | 4.23 | 3.99 | 8.82 | 11.25 | 13.09 | |||||
Common Equity, 3 Yr. CAGR % | 2.78 | -7.93 | 17.22 | 11.9 | 23.79 | |||||
Tangible Book Value, 3 Yr. CAGR % | 1.56 | -11.45 | 20.24 | 13.35 | 28.33 | |||||
Cash From Operations, 3 Yr. CAGR % | 1.5 | -5.72 | -2.54 | 0.81 | 19.07 | |||||
Capital Expenditures, 3 Yr. CAGR % | -7.94 | -3.44 | 23.99 | 36.52 | 39.41 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -29.1 | 4.02 | 146.52 | 112.35 | 63.08 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -21.18 | -30.87 | 96.03 | 113.85 | 181.14 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.04 | 2.2 | 4.78 | 6.02 | 5.66 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.53 | 4.95 | 5.52 | 5.57 | 9.15 | |||||
Gross Profit, 5 Yr. CAGR % | -15.93 | -1.17 | -2.16 | 0.45 | 12.26 | |||||
EBITDA, 5 Yr. CAGR % | 1.3 | 1.26 | 0.26 | 2.28 | 9.98 | |||||
EBITA, 5 Yr. CAGR % | 0.05 | -0.66 | -2.31 | 0.82 | 12.98 | |||||
EBIT, 5 Yr. CAGR % | -0.03 | -0.74 | -2.37 | 0.81 | 13 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -22.97 | -11.21 | -14.96 | 7.63 | 11.82 | |||||
Net Income, 5 Yr. CAGR % | -23.95 | -12.16 | -14.96 | 7.63 | 11.82 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -23.73 | -12.35 | -17.5 | 2.88 | 6.8 | |||||
Normalized Net Income, 5 Yr. CAGR % | -2.19 | -11.76 | -12.58 | 0.28 | 14.85 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.96 | 5.07 | 5.56 | 6.73 | 8.75 | |||||
Inventory, 5 Yr. CAGR % | 14.58 | 13.86 | 14.03 | 8.15 | 9.28 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.76 | 11.68 | 10.13 | 8.97 | 13.34 | |||||
Total Assets, 5 Yr. CAGR % | 5.04 | 5.21 | 6.84 | 8.05 | 9.77 | |||||
Common Equity, 5 Yr. CAGR % | 6.48 | -0.53 | 9.52 | 7.32 | 10.09 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.45 | -3.91 | 10.11 | 7.72 | 10.65 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.44 | -0.46 | -0.91 | 0.4 | 7.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | 3.29 | 2.83 | 8.38 | 14.85 | 25.31 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.87 | 107.5 | 21.98 | 29.76 | 90.56 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 13.87 | -20.71 | 28.06 | 40.25 | 69.92 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.62 | 4.3 | 4.59 | 3.99 | 4.41 |
- Stock Market
- Stocks
- SVT Stock
- Financials Severn Trent Plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















